88124-42-9 | Monensin, 26-(cyclohexylcarbamate),monosodium salt (9CI) | C43H73 N O12 . Na |
88124-48-5 | Monensin,26-[(4-chlorophenyl)carbamate], monosodium salt (9CI) | C43H66 Cl N O12 . Na |
88124-47-4 | Monensin, 26-[(4-iodophenyl)carbamate],monosodium salt (9CI) | C43H66 I N O12 . Na |
88124-44-1 | Monensin,26-(phenylcarbamate), monosodium salt (9CI) | C43H67 N O12 . Na |
88124-46-3 | Monensin,26-[(4-fluorophenyl)carbamate], monosodium salt (9CI) | C43H66 F N O12 . Na |
88124-40-7 | Monensin,16-deethyl-16-methyl-, 26-[(1-phenylethyl)carbamate], monosodium salt, [26(R)]-(9CI) | C44H69 N O12 . Na |
88124-41-8 | Monensin,16-deethyl-16-methyl-, 26-[(1-phenylethyl)carbamate], monosodium salt, [26(S)]-(9CI) | C44H69 N O12 . Na |
88124-27-0 | etazepine | C17H17 N O2 |
88124-05-4 | 2-Quinoxalinecarboxamide, 3-methyl-N-[1-methyl-2-(phenylthio)ethyl]-, 1,4-dioxide | C19H19N3O3S |
88124-06-5 | 2-Quinoxalinecarboxamide, 3-methyl-N-[1-methyl-2-(methylthio)ethyl]-, 1,4-dioxide | C14H17N3O3S |
88124-07-6 | 2-Quinoxalinecarboxamide, N-[2-(ethylthio)-1-methylethyl]-3-methyl-, 1,4-dioxide | C15H19N3O3S |
88124-34-9 | Hydrazinecarboxylic acid, 2-phenyl-2-[1-(phenylmethyl)-1H-tetrazol-5-yl]-, phenylmethyl ester | C22H20N6O2 |
88124-53-2 | Carbamic acid, [2-(fluoromethyl)-1-(4-methoxyphenyl)-4-oxo-3-azetidinyl]-, phenylmethyl ester, cis- | C19H19FN2O4 |
88124-54-3 | Carbamic acid, [2-(fluoromethyl)-4-oxo-3-azetidinyl]-, phenylmethyl ester, cis- | C12H13FN2O3 |
88124-69-0 | 1,3,4-Thiadiazole-2-acetic acid, a-(methoxyimino)-5-[(triphenylmethyl)amino]-, (E)- | C24H20N4O3S |
88124-70-3 | 1,3,4-Thiadiazole-2-acetic acid, 5-[(chloroacetyl)amino]-a-(methoxyimino)-, (E)- | C7H7ClN4O4S |
88124-71-4 | 1,3,4-Thiadiazole-2-acetic acid, 5-[(chloroacetyl)amino]-a-(methoxyimino)-, (Z)- | C7H7ClN4O4S |
88124-96-3 | 1H-Isoindole-1,3(2H)-dione, 2-[5-(3,3-dimethyloxiranyl)-3-methyl-2-pentenyl]-, (E)- | C18H21NO3 |